Literature DB >> 16820910

Inflammatory infiltration, fibrosis, necrosis and mucinous content in relation to clinicopathological and molecular factors in rectal cancers with or without preoperative radiotherapy.

Annica Knutsen1, Gunnar Adell, Xiao-Feng Sun.   

Abstract

The association between inflammatory infiltration, fibrosis, necrosis and mucinous content in rectal cancers, and their relationship to preoperative radiotherapy (RT) clinicopathological and biological factors (p53, apoptosis and Cox-2) is not fully characterised. We analysed these histopathological parameters and their relationships in rectal cancer patients who participated in a clinical trial of preoperative RT. One hundred and forty-eight preoperative biopsies and 153 surgically resected tumours were examined. Of the surgical specimens, 81 had surgery alone and 72 received RT before surgery. A higher grade of inflammatory infiltration was related to favourable survival in the whole group of patients (p=0.004, for multivariate analysis p=0.01) as well as in the subgroups of patients with (p=0.04) or without RT (p=0.01). After RT, tumours showed a decreased infiltration (p=0.0003) and increased necrosis (p=0.006), strong necrosis was related to favourable survival (p=0.046). Necrosis (p=0.054) and fibrosis (p=0.06) tended to be increased in p53-negative tumours after RT. Inflammatory infiltration was a strong prognostic factor in rectal cancer patients, regardless of RT. RT tended to induce necrosis and fibrosis in p53-negative tumours.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820910

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  pRb2/p130 protein in relation to clinicopathological and biological variables in rectal cancers with a clinical trial of preoperative radiotherapy.

Authors:  Satish Babu Moparthi; Viveka Bergman; Gunnar Adell; Sten Thorstensson; Xiao-Feng Sun
Journal:  Int J Colorectal Dis       Date:  2009-07-14       Impact factor: 2.571

2.  Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial: prognostic value and effects of preoperative radio (chemo) therapy.

Authors:  Annelies Debucquoy; Louis Libbrecht; Valerie Roobrouck; Laurence Goethals; William McBride; Karin Haustermans
Journal:  Eur J Cancer       Date:  2008-03-18       Impact factor: 9.162

3.  Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer.

Authors:  Wen-Jian Meng; Surajit Pathak; Zhen-Yu Ding; Hong Zhang; Gunnar Adell; Birgitta Holmlund; Yuan Li; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy--a study in a Swedish rectal cancer trial of preoperative radiotherapy.

Authors:  Annica Holmqvist; Jingfang Gao; Birgitta Holmlund; Gunnar Adell; John Carstensen; Dianne Langford; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2012-02-10       Impact factor: 4.430

5.  The prognostic factors and multiple biomarkers in young patients with colorectal cancer.

Authors:  Mo-Jin Wang; Jie Ping; Yuan Li; Gunnar Adell; Gunnar Arbman; Bjorn Nodin; Wen-Jian Meng; Hong Zhang; Yong-Yang Yu; Cun Wang; Lie Yang; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Sci Rep       Date:  2015-05-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.